Publication | Closed Access

Moderate Dose, Three-Drug Therapy With Niacin, Lovastatin, and Colestipol to Reduce Low-Density Lipoprotein Cholesterol <100 mg/dl in Patients With Hyperlipidemia and Coronary Artery Disease

Cardiovascular DiseaseThree-drug TherapyMedicineCardiovascular PharmacologyLow-density Lipoprotein CholesterolHyperlipidemiaPharmacotherapyPharmacologyDyslipidemiaModerate Dose